Domov › Parkinsonova bolezen › Kansas
Klinične študije za Parkinsonova bolezen v Kansas
10 študij za Parkinsonova bolezen išče udeležence na lokacijah v Kansas.
Mesta v Kansas
Uradno besedilo študije (angleško)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Vključevanje udeležencevFaza 2
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-029, Kansas City
Vključevanje udeležencevFaza 2/3
Starost 40–80 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
Vključevanje udeležencevFaza 2/3
Starost 40–85 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- The University of Kansas (KU) (Site #216), Kansas City
Vključevanje udeležencevFaza 2
Starost 30–80 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kansas, Lawrence
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Vključevanje udeležencevFaza 3
Starost 50–85 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Vključevanje udeležencevFaza 3
Starost 45–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2025 · NCT06765668Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.